Plumbline Life Sciences

Plumbline Life Sciences, Inc. develops DNA therapies for animals. It has developed LifeTide SW5, a pig DNA therapy; PLS-IF1000, a DNA vaccine for foot-and-mouth disease; PLS-B3000, a cattle DNA therapy; PLS-H1000, a treatment for laminitis; PLS-D5000, a cancer immunotherapy targeting cancer; PLS-D1000, a product addressing anemia symptoms caused by renal failure in dogs and cats; and PLS-C2000, a product addressing anemia symptoms caused by renal failure in cats.